Lever VC, a New York and Hong Kong-based venture capital firm that invests in early-stage alternative protein startups, has reached the first close of Lever VC Fund I with $23 million in capital commitments, it announced in a statement on Monday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
